DE60135919D1 - Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate - Google Patents
Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivateInfo
- Publication number
- DE60135919D1 DE60135919D1 DE60135919T DE60135919T DE60135919D1 DE 60135919 D1 DE60135919 D1 DE 60135919D1 DE 60135919 T DE60135919 T DE 60135919T DE 60135919 T DE60135919 T DE 60135919T DE 60135919 D1 DE60135919 D1 DE 60135919D1
- Authority
- DE
- Germany
- Prior art keywords
- chinazole
- heterocyclylmethyl
- chinoline
- inhibiting
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00203368 | 2000-09-25 | ||
EP01202190 | 2001-06-07 | ||
PCT/EP2001/010894 WO2002024686A2 (en) | 2000-09-25 | 2001-09-18 | Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60135919D1 true DE60135919D1 (de) | 2008-11-06 |
Family
ID=26072730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60135919T Expired - Lifetime DE60135919D1 (de) | 2000-09-25 | 2001-09-18 | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate |
Country Status (8)
Country | Link |
---|---|
US (1) | US7196094B2 (de) |
EP (1) | EP1322650B1 (de) |
JP (1) | JP4974438B2 (de) |
AT (1) | ATE409189T1 (de) |
AU (1) | AU2002220559A1 (de) |
DE (1) | DE60135919D1 (de) |
ES (1) | ES2313991T3 (de) |
WO (1) | WO2002024686A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2361B1 (en) | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl |
US6713462B2 (en) | 2001-06-21 | 2004-03-30 | Ariad Pharmaceuticals, Inc. | Quinolinones and uses thereof |
ATE364384T1 (de) | 2002-03-22 | 2007-07-15 | Janssen Pharmaceutica Nv | Benzylimidazolyl substituierte 2-chinolon und chinazolinon derivate zur verwendung als farnesyl transferase inhibitoren |
ATE336496T1 (de) | 2002-04-15 | 2006-09-15 | Janssen Pharmaceutica Nv | Farnesyl transferase hemmende tricyclische quinazolinederivate substitutiert mit kohlenstoff-gebundenen imidazolen oder triazolen |
TW200504057A (en) * | 2003-02-27 | 2005-02-01 | Chugai Pharmaceutical Co Ltd | Benzothiophene derivative |
JP4722851B2 (ja) * | 2003-09-23 | 2011-07-13 | メルク・シャープ・エンド・ドーム・コーポレイション | キノリンカリウムチャネル阻害剤 |
US20050154451A1 (en) * | 2003-12-18 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
WO2005089518A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Uch-l1 expression and cancer therapy |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
EP1744751A4 (de) * | 2004-03-18 | 2010-03-10 | Brigham & Womens Hospital | Verfahren zur behandlung von synucleinopathien |
CA2559282A1 (en) * | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20060106060A1 (en) * | 2004-03-18 | 2006-05-18 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies (Lansbury) |
WO2006017369A2 (en) * | 2004-07-13 | 2006-02-16 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of a farnesyl transferase inhibitor in the treatment of viral infections |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
WO2007075923A2 (en) | 2005-12-23 | 2007-07-05 | Link Medicine Corporation | Treatment of synucleinopathies |
EP1991531A1 (de) * | 2006-02-28 | 2008-11-19 | Amgen Inc. | Cinnolin- und chinoxalinderivate als phosphodiesterase-10-hemmer |
WO2009151683A2 (en) * | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
CA2743449C (en) | 2008-11-12 | 2016-10-18 | Ariad Pharmaceuticals, Inc. | Pyrazinopyrazines and derivatives as kinase inhibitors |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
BRPI0920927A2 (pt) * | 2008-11-13 | 2019-09-24 | Link Medicine Corp | derivados de azaquinolinona e usos dos mesmos |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
US9303015B2 (en) | 2012-10-16 | 2016-04-05 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORγt |
ES2628365T3 (es) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T |
MX358508B (es) | 2012-10-16 | 2018-08-22 | Janssen Pharmaceutica Nv | Moduladores de quinolinilo unidos a metileno de receptor nuclear de acido retinoico-gamma-t. |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
CA2927182A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Quinolinyl modulators of ror.gamma.t |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
EP3057421B1 (de) | 2013-10-15 | 2019-11-20 | Janssen Pharmaceutica NV | Alkylgebundene chinolinylmodulatoren von roryt |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2002864C (en) | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
DE69620445T2 (de) | 1995-12-08 | 2002-12-12 | Janssen Pharmaceutica Nv | (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren |
TW591030B (en) | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
PL190944B1 (pl) * | 1997-04-25 | 2006-02-28 | Janssen Pharmaceutica Nv | Pochodna chinazolinonu i sposób jej wytwarzania oraz kompozycja farmaceutyczna i sposób jej wytwarzania |
RU2209066C2 (ru) | 1997-06-02 | 2003-07-27 | Янссен Фармацевтика Н.В. | Производные (имидазол-5-ил)метил-2-хинолинона в качестве ингибиторов пролиферации клеток гладкой мышцы |
HU229358B1 (en) | 1998-07-06 | 2013-11-28 | Janssen Pharmaceutica Nv | Farnesyl protein transferase inhibitors for treating arthropathies |
ES2199579T3 (es) | 1998-07-06 | 2004-02-16 | Janssen Pharmaceutica N.V. | Inhibidores de la proteina farnesil-transferasa con propiedades de sensibilizacion in vivo. |
NZ509372A (en) | 1998-08-27 | 2003-08-29 | Pfizer Prod Inc | Substituted quinolin-2-one derivatives, pharmaceuticals thereof and their use for treating abnormal cell growth (e.g. cancer) |
WO2000012498A1 (en) * | 1998-08-27 | 2000-03-09 | Pfizer Products Inc. | Quinolin-2-one derivatives useful as anticancer agents |
DE69907964T2 (de) * | 1998-12-23 | 2004-02-19 | Janssen Pharmaceutica N.V. | 1,2-annelierte chinolinderivate |
OA11833A (en) * | 1999-02-11 | 2005-08-23 | Pfizer Prod Inc | Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents. |
-
2001
- 2001-09-18 AU AU2002220559A patent/AU2002220559A1/en not_active Abandoned
- 2001-09-18 EP EP01985254A patent/EP1322650B1/de not_active Expired - Lifetime
- 2001-09-18 DE DE60135919T patent/DE60135919D1/de not_active Expired - Lifetime
- 2001-09-18 AT AT01985254T patent/ATE409189T1/de not_active IP Right Cessation
- 2001-09-18 US US10/381,361 patent/US7196094B2/en not_active Expired - Lifetime
- 2001-09-18 JP JP2002529096A patent/JP4974438B2/ja not_active Expired - Fee Related
- 2001-09-18 WO PCT/EP2001/010894 patent/WO2002024686A2/en active IP Right Grant
- 2001-09-18 ES ES01985254T patent/ES2313991T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2002220559A1 (en) | 2002-04-02 |
ATE409189T1 (de) | 2008-10-15 |
EP1322650A2 (de) | 2003-07-02 |
US20030207887A1 (en) | 2003-11-06 |
EP1322650B1 (de) | 2008-09-24 |
JP4974438B2 (ja) | 2012-07-11 |
ES2313991T3 (es) | 2009-03-16 |
JP2004509887A (ja) | 2004-04-02 |
WO2002024686A2 (en) | 2002-03-28 |
WO2002024686A3 (en) | 2002-06-13 |
US7196094B2 (en) | 2007-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
SE0000540D0 (sv) | New compounds | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
CY1105386T1 (el) | Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου | |
DE60033316D1 (de) | Tricyclische proteinkinasehemmer | |
CY1105575T1 (el) | Ενωσεις αμιδιου και χρηση αυτων | |
DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
JO2654B1 (en) | Multiple aryl caroxa amides are useful as lipid - lowering agents | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
CY1111317T1 (el) | Παραγωγα 4-φαινυλοπυριδινης και χρηση αυτων ως ανταγωνιστων υποδοχεων της νκ-1 | |
CY1109886T1 (el) | Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες | |
EA199900373A2 (ru) | Фармацевтические композиции | |
BR0213981A (pt) | Fotoiniciadores difuncionais | |
EA200300566A1 (ru) | Применение cci-779 в качестве противоопухолевого средства | |
GB0127903D0 (en) | Improvements relating to organic compounds | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
PT1181294E (pt) | Novos derivados e analogos da galantamina | |
SE0103710D0 (sv) | Compounds | |
SE9801494D0 (sv) | Novel use | |
SV2003000981A (es) | Fenil-heterociclil-eteres ref. pcs10973 | |
BRPI0416678A (pt) | pirazolpirimidinas | |
DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
BR0206922A (pt) | Compostos orgânicos | |
ATE321760T1 (de) | N-aryl-2-oxazolidinone und deren derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |